ID

19904

Beschreibung

The purpose of this study is to determine the safety and efficacy of natalizumab in the treatment of individuals who have been diagnosed with relapsing remitting multiple sclerosis (MS). It is hoped that natalizumab will prevent certain types of white blood cells from moving out of the bloodstream into organs, including the brain, that are being damaged by autoimmune disease (a disease in which the body's own immune system attacks certain organs). These white blood cells are thought to cause inflammation that can result in lesions (small areas of damage) in the brain. These lesions are thought to be the cause of relapses and disability in MS.

Stichworte

Versionen (1)
  1. 30.01.17 30.01.17 -
Hochgeladen am

30. Januar 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Telephone Visit CRFs Multiple Sclerosis Tysabri NCT00027300

Englisch

Telephone Visit CRFs Multiple Sclerosis Tysabri NCT00027300

1 Formulare  
Telephone Visit
Beschreibung

Telephone Visit

Alias
UMLS CUI-1
C0178941
contact not made
Beschreibung

contact not made

Datentyp

boolean

Alias
UMLS CUI [1]
C1705415
date of contact
Beschreibung

date of contact

Datentyp

date

Alias
UMLS CUI [1]
C0805839
Person contacted
Beschreibung

person contacted

Datentyp

text

Alias
UMLS CUI [1]
C0337611
If other, specify:
Beschreibung

other person contacted

Datentyp

text

Alias
UMLS CUI [1,1]
C0337611
UMLS CUI [1,2]
C3146298
Since the subject was last contacted, has the subject experienced any new or continuing adverse events? (If Yes, please record adverse event(s) in the CRF)
Beschreibung

adverse event

Datentyp

boolean

Alias
UMLS CUI [1]
C0877248
Since the subject was last contacted, has the subject received any concomitant medications? (Includes IV steroid therapy and alternate MS therapy. If Yes, please record concomitant medications in the CRF)
Beschreibung

concomitant medication

Datentyp

boolean

Alias
UMLS CUI [1]
C2347852
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Telephone Visit CRFs Multiple Sclerosis Tysabri NCT00027300

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Telephone Visit
C0178941 (UMLS CUI-1)
contact not made
Item
contact not made
boolean
C1705415 (UMLS CUI [1])
date of contact
Item
date of contact
date
C0805839 (UMLS CUI [1])
Item
Person contacted
text
C0337611 (UMLS CUI [1])
person contacted
Code List
Person contacted
CL Item
Subject (Subject)
CL Item
Other (Other)
other person contacted
Item
If other, specify:
text
C0337611 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
adverse event
Item
Since the subject was last contacted, has the subject experienced any new or continuing adverse events? (If Yes, please record adverse event(s) in the CRF)
boolean
C0877248 (UMLS CUI [1])
concomitant medication
Item
Since the subject was last contacted, has the subject received any concomitant medications? (Includes IV steroid therapy and alternate MS therapy. If Yes, please record concomitant medications in the CRF)
boolean
C2347852 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video